Janney Montgomery Scott’s ADMA Biologics ADMA Stock Holding History

Janney Montgomery Scott’s Portfolio ADMA Stock Details ADMA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$140K	Sell	13,957 -169	-1%	-$1.56K	﹤0.01%	3073
2026 Q2	$118K	Sell	14,126 -62,992	-82%	-$574K	﹤0.01%	3055
2026 Q1	$695K	Buy	77,118 +7,744	+11%	+$122K	﹤0.01%	1855
2025 Q4	$1.26M	Buy	69,374 +2,579	+4%	+$43.5K	﹤0.01%	1598
2025 Q3	$979K	Buy	66,795 +15,448	+30%	+$265K	﹤0.01%	1705
2025 Q2	$935K	Sell	51,347 -19,644	-28%	-$401K	﹤0.01%	1616
2025 Q1	$1.41M	Buy	70,991 +4,865	+7%	+$84.1K	﹤0.01%	1335
2024 Q4	$1.13M	Sell	66,126 -6,603	-9%	-$124K	﹤0.01%	1473
2024 Q3	$1.45M	Buy	+72,729	New	+$1.13M	﹤0.01%	1304

Other funds holding ADMA

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 38.25% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM

Capital Research Global Investors Los Angeles, California $704B AUM 26.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return

Kennedy Capital Management St Louis, Missouri $5.31B AUM 40.5% 1-Year Est. Return

Janney Montgomery Scott's ADMA Position: Q3 2026 in Review

Janney Montgomery Scott reduced its ADMA Biologics (ADMA) stake by 1.2% in Q3 2026, selling an estimated $1.56K and leaving 13,957 shares worth $140K. The position accounts for ﹤0.01% of the portfolio, ranked #3073.

Janney Montgomery Scott first reported a position in ADMA in Q3 2024 and has held it in 9 quarters since. The position peaked at $1.45M in Q3 2024. 238 funds tracked by Wall St. Rank hold ADMA as of Q3 2026.

Janney Montgomery Scott held 13,957 shares of ADMA Biologics worth $140K as of Q3 2026.
Janney Montgomery Scott sold 169 ADMA Biologics shares in Q3 2026, an estimated $1.56K.
ADMA Biologics made up ﹤0.01% of Janney Montgomery Scott's portfolio in Q3 2026, its #3073 holding.
Janney Montgomery Scott first reported a position in ADMA Biologics in Q3 2024 and has held it in 9 quarters since.
Janney Montgomery Scott's ADMA Biologics position peaked at $1.45M in Q3 2024.
238 funds tracked by Wall St. Rank held ADMA Biologics as of Q3 2026.

Based on Janney Montgomery Scott's 13F filing for Q3 2026, filed 12 Nov 2026.